期刊论文详细信息
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 卷:1802
Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation
Article
Banerjee, Sanjay K.1  McGaffin, Kenneth R.1  Huang, Xueyin N.1  Ahmad, Ferhaan1,2 
[1] Univ Pittsburgh, Cardiovasc Inst, Dept Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA
关键词: AMPK;    Hypertrophy;    AKT;    NF-kappa B;    Transgenic Mouse;    Heart;   
DOI  :  10.1016/j.bbadis.2009.12.001
来源: Elsevier
PDF
【 摘 要 】

Human mutations in PRKAG2, the gene encoding the gamma 2 subunit of AMP activated protein kinase (AMPK), cause a glycogen storage cardiomyopathy. In a transgenic mouse with cardiac specific expression of the Thr400Asn mutation in PRKAG2 (TG(T400N)), we previously reported initial cardiac hypertrophy (ages 28 weeks) followed by dilation and failure (ages 12-20 weeks). We sought to elucidate the molecular mechanisms of cardiac hypertrophy. TG(T400N) Mice showed significantly increased cardiac mass/body mass ratios up to similar to 3-fold beginning at age 2 weeks. Cardiac expression of ANP and BNP were similar to 2- and similar to 5-fold higher, respectively, in TG(T400N) relative to wildtype (WT) mice at age 2 weeks. NF-kappa B activity and nuclear translocation of the p50 subunit were increased similar to 2- to 3-fold in TG(T400N) hearts relative to WT during the hypertrophic phase. Phosphorylated Akt and p70S6K were elevated similar to 2-fold as early as age 2 weeks. To ascertain whether these changes in TG(T400N) Mice were a consequence of increased AMPK activity, we crossbred TG(T400N) with TG(alpha 2DN) mice, which express a dominant negative, kinase dead mutant of the AMPK alpha 2 catalytic subunit and have low myocardial AMPK activity. Genetic reversal of AMPK overactivity led to a reduction in hypertrophy, nuclear translocation of NF-kappa B, phosphorylated Akt, and p70S6K. We conclude that inappropriate activation of AMPK secondary to the T400N PRKAG2 mutation is associated with the early activation of NF-kappa B and Akt signaling pathway, which mediates cardiac hypertrophy. (C) 2009 Elsevier B.V. All rights reserved.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_bbadis_2009_12_001.pdf 991KB PDF download
  文献评价指标  
  下载次数:3次 浏览次数:0次